Women's Health Market Projected to Hit $600 Billion by 2030 as Longevity Focus Grows
The Global Wellness Summit reports the women's health market is on track to reach $600 billion by 2030, driven by new focus on longevity, hormonal health, and conditions that affect women differently than men. Clinics, wearables, and telehealth platforms are all shifting to address women's biology.
The women's health market is projected to reach $600 billion by 2030, according to a report released by the Global Wellness Summit on April 28, 2026. The growth reflects a shift toward lifelong care that addresses conditions affecting women differently, disproportionately, or exclusively.
The report identified longevity as a key driver. Researchers and clinicians are moving beyond menopause symptom management to address ovarian aging with interventions tailored to all stages of a woman's life. This includes new diagnostics, hormone therapies, and preventive care protocols.
Clinics, wellness resorts, telehealth platforms, wearables, and diagnostics companies are all reorienting toward women's biology. The report noted that female athletes are gaining more visibility, and participation in women's sports is surging globally, which is driving demand for sports medicine and performance health products designed for women.
"For too long, most medical research used male subjects as the default," said a Global Wellness Summit analyst. "The industry is finally catching up, and the market opportunity is enormous."
The report also highlighted neurowellness as a growing area within women's health. Women are disproportionately affected by anxiety, depression, and autoimmune conditions, and new products and services are targeting nervous system regulation and emotional resilience.
Personalized health memberships are becoming more common, offering continuous care, telehealth access, personalized health dashboards, and coaching. Wellness retreats are also becoming more tailored, with programs built around pre-arrival health assessments.
The Global Wellness Summit said the $600 billion projection is conservative and could be exceeded if regulatory barriers to new treatments are reduced and if insurance coverage for women's health services expands.
